Metabotropic glutamate receptors regulate cortical gamma hyperactivities elicited by ketamine in rats

Neuroscience Letters

Volumn 567, Issue , 2014, Pages 30-34

  Hiyoshi, Tetsuaki ^a   Hikichi, Hirohiko ^a   Karasawa, Jun ichi ^a   Chaki, Shigeyuki ^a  

^a TAISHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

EEG; Gamma; Ketamine; MGlu1 receptor antagonist; MGlu2 3 receptor agonist; Oscillations

Indexed keywords

4 AMINO 2 OXABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID; JNJ 16259685; KETAMINE; METABOTROPIC RECEPTOR; METABOTROPIC RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DOSE RESPONSE; DRUG EFFECT; ELECTRODE IMPLANT; ELECTROENCEPHALOGRAM; FRONTAL CORTEX; HYPERACTIVITY; MALE; NONHUMAN; OSCILLATION; PRIORITY JOURNAL; RAT;

EEG; GAMMA; KETAMINE; MGLU1 RECEPTOR ANTAGONIST; MGLU2/3 RECEPTOR AGONIST; OSCILLATIONS;

AMINO ACIDS; ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; ELECTROENCEPHALOGRAPHY; FRONTAL LOBE; KETAMINE; MALE; QUINOLINES; RATS, SPRAGUE-DAWLEY; RECEPTORS, METABOTROPIC GLUTAMATE;

EID: 84897952412     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2014.03.025     Document Type: Article

References (36)

1. Javitt D.C. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions. Int. Rev. Neurobiol. 2007, 78:69-108.
2. Moghaddam B. Bringing order to the glutamate chaos in schizophrenia. Neuron 2003, 40:881-884.
3. Rujescu D., Bender A., Keck M., Hartmann A.M., Ohl F., Raeder H., Giegling I., Genius J., McCarley R.W., Möller H.J., Grunze H. A pharmacological model for psychosis based on N-methyl-D-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities. Biol. Psychiatry 2006, 59:721-729.
4. Krystal J.H., D'Souza D.C., Mathalon D., Perry E., Belger A., Hoffman R. NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. Psychopharmacology (Berl.) 2003, 169:215-233.
5. Adler C.M., Goldberg T.E., Malhotra A.K., Pickar D., Breier A. Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers. Biol. Psychiatry 1998, 43:811-816.
6. Hetem L.A., Danion J.M., Diemunsch P., Brandt C. Effect of a subanesthetic dose of ketamine on memory and conscious awareness in healthy volunteers. Psychopharmacology (Berl.) 2000, 152:283-288.
7. Krystal J.H., Karper L.P., Seibyl J.P., Freeman G.K., Delaney R., Bremner J.D., Heninger G.R., Bowers M.B., Charney D.S. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch. Gen. Psychiatry 1994, 51:199-214.
8. Newcomer J.W., Farber N.B., Jevtovic-Todorovic V., Selke G., Melson A.K., Hershey T., Craft S., Olney J.W. Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis. Neuropsychopharmacology 1999, 20:106-118.
9. Satow A., Suzuki G., Maehara S., Hikichi H., Murai T., Murai T., Kawagoe-Takaki H., Hata M., Ito S., Ozaki S., Kawamoto H., Ohta H. Unique antipsychotic activities of the selective metabotropic glutamate receptor 1 allosteric antagonist 2-cyclopropyl-5-[1-(2-fluoro-3-pyridinyl)-5-methyl-1H-1,2,3-triazol-4-yl]-2,3-dihydro-1H-isoindol-1-one. J. Pharmacol. Exp. Ther. 2009, 330:179-190.
10. Hikichi H., Kaku A., Karasawa J., Chaki S. Stimulation of metabotropic glutamate (mGlu) 2 receptor and blockade of mGlu1 receptor improve social memory impairment elicited by MK-801 in rats. J. Pharmacol. Sci. 2013, 122:10-16.
11. Nakazato A., Kumagai T., Sakagami K., Yoshikawa R., Suzuki Y., Chaki S., Ito H., Taguchi T., Nakanishi S., Okuyama S. Synthesis, SARs, and pharmacological characterization of 2-amino-3 or 6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives as potent, selective, and orally active group II metabotropic glutamate receptor agonists. J. Med. Chem. 2000, 43:4893-4909.
12. 1A dependent. Behav. Brain Res. 2013, 256:298-304.
13. Buzsaki G., Draguhn A. Neuronal oscillations in cortical networks. Science 2004, 304:1926-1929.
14. Uhlhaas P.J., Singer W. Neural synchrony in brain disorders: relevance for cognitive dysfunctions and pathophysiology. Neuron 2006, 52:155-168.
15. Uhlhaas P.J., Singer W. Abnormal neural oscillations and synchrony in schizophrenia. Nat. Rev. Neurosci. 2010, 11:100-113.
16. Spencer K.M. Baseline gamma power during auditory steady-state stimulation in schizophrenia. Front. Hum. Neurosci. 2012, 5:190.
17. Winterer G., Coppola R., Goldberg T.E., Egan M.F., Jones D.W., Sanchez C.E., Weinberger D.R. Prefrontal broadband noise, working memory, and genetic risk for schizophrenia. Am. J. Psychiatry 2004, 161:490-500.
18. Suazo V., Díez Á., Martín C., Ballesteros A., Casado P., Martín-Loeches M., Molina V. Elevated noise power in gamma band related to negative symptoms and memory deficit in schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2012, 38:270-275.
19. Spencer K.M., Nestor P.G., Perlmutter R., Niznikiewicz M.A., Klump M.C., Frumin M., Shenton M.E., McCarley R.W. Neural synchrony indexes disordered perception and cognition in schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:17288-17293.
20. Hong L.E., Summerfelt A., Buchanan R.W., O'Donnell P., Thaker G.K., Weiler M.A., Lahti A.C. Gamma and delta neural oscillations and association with clinical symptoms under subanesthetic ketamine. Neuropsychopharmacology 2010, 35:632-640.
21. D-aspartic acid receptor antagonist-induced frequency oscillations in mice recreate pattern of electrophysiological deficits in schizophrenia. Neuroscience 2009, 158:705-712.
22. Pinault D. N-methyl d-aspartate receptor antagonists ketamine and MK-801 induce wake-related aberrant gamma oscillations in the rat neocortex. Biol. Psychiatry 2008, 63:730-735.
23. Hakami T., Jones N.C., Tolmacheva E.A., Gaudias J., Chaumont J., Salzberg M., O'Brien T.J., Pinault D. NMDA receptor hypofunction leads to generalized and persistent aberrant gamma oscillations independent of hyperlocomotion and the state of consciousness. PLoS One 2009, 4:e6755.
24. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1998, Elsevier/Academic Press, New York. fourth ed.
25. Jones N.C., Reddy M., Anderson P., Salzberg M.R., O'Brien T.J., Pinault D. Acute administration of typical and atypical antipsychotics reduces EEG γ power, but only the preclinical compound LY379268 reduces the ketamine-induced rise in γ power. Int. J. Neuropsychopharmacol. 2012, 15:657-668.
26. Steckler T., Oliveira A.F., van Dyck C., van Craenendonck H., Mateus A.M., Langlois X., Lesage A.S., Prickaerts J. Metabotropic glutamate receptor 1 blockade impairs acquisition and retention in a spatial Water maze task. Behav. Brain Res. 2005, 164:52-60.
27. Traub R.D., Jefferys J.G., Whittington M.A. Simulation of gamma rhythms in networks of interneurons and pyramidal cells. J. Comput. Neurosci. 1997, 4:141-150.
28. Grunze H.C., Rainnie D.G., Hasselmo M.E., Barkai E., Hearn E.F., McCarley R.W., Greene R.W. NMDA-dependent modulation of CA1 local circuit inhibition. J. Neurosci. 1996, 16:2034-2043.
29. Homayoun H., Moghaddam B. NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J. Neurosci. 2007, 27:11496-11500.
30. Korotkova T., Fuchs E.C., Ponomarenko A., von Engelhardt J., Monyer H. NMDA receptor ablation on parvalbumin-positive interneurons impairs hippocampal synchrony, spatial representations, and working memory. Neuron 2010, 68:557-569.
31. Carlén M., Meletis K., Siegle J.H., Cardin J.A., Futai K., Vierling-Claassen D., Rühlmann C., Jones S.R., Deisseroth K., Sheng M., Moore C.I., Tsai L.H. A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior. Mol. Psychiatry 2012, 17:537-548.
32. Homayoun H., Jackson M.E., Moghaddam B. Activation of metabotropic glutamate 2/3 receptors reverses the effects of NMDA receptor hypofunction on prefrontal cortex unit activity in awake rats. J. Neurophysiol. 2005, 93:1989-2001.
33. Moghaddam B., Adams B.W. Reversal of phencyclidine effects by a group II metabotropic receptor agonist in rats. Science 1998, 281:1349-1352.
34. Melendez R.I., Vuthiganon J., Kalivas P.W. Regulation of extracellular glutamate in the prefrontal cortex: focus on the cystine glutamate exchanger and group I metabotropic glutamate receptors. J. Pharmacol. Exp. Ther. 2005, 314:139-147.
35. Yizhar O., Fenno L.E., Prigge M., Schneider F., Davidson T.J., O'Shea D.J., Sohal V.S., Goshen I., Finkelstein J., Paz J.T., Stehfest K., Fudim R., Ramakrishnan C., Huguenard J.R., Hegemann P., Deisseroth K. Neocortical excitation/inhibition balance in information processing and social dysfunction. Nature 2011, 477:171-178.
36. B-mediated rescue of altered excitatory-inhibitory balance, gamma synchrony and behavioral deficits following constitutive NMDAR-hypofunction. Transl. Psychiatry 2012, 2:e142.